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Objective: To evaluate the temporal distribution (1991–2009) and associated variation of KSHV
subtypes in Cuba.
Method: Phylogenetic characterization based on the KSHV K1 gene was performed using 90 KSHV
positive samples.
Results: Molecular characterization conﬁrmed the prevalence of a wide range of KSHV subtypes
(A: n¼48 [A5¼12]; C: n¼15; B: n¼22; and E: n¼5). In the current study, we observed a signiﬁcant
increase in HHV-8 subtype B after 2004 (p¼0.0063). This Subtype B in Cuba was associated with:
heterosexual behaviour (OR: 3.63, CI: 1,2–10,98; p¼0.03), with the antecedent of acquiring HIV/KSHV
in Africa (p¼0.0003), with nodular stage of KS lesions (OR 4.2, CI: 1.1 to 15.7; p¼0.04).
Conclusion: Our study is the ﬁrst to report KSHV Subtype B expansion in Cuba, that might be reﬂective
of a change in human behavioural pattern.
& 2012 Elsevier Inc. All rights reserved.Introduction
Kaposis Sarcoma (KS) was ﬁrst described in 1872. Four major
clinical forms have since been described, namely, classic, endemic,
iatrogenic, and epidemic or Acquired Immunodeﬁciency Syndrome
(AIDS)-associated (Goetschel, 1959; Iversen et al., 1980; Schwartz,
2004; Sengupta et al., 1986). Kaposis Sarcoma Associated Herpes-
virus (KSHV), also known as Human Herpesvirus 8 (HHV-8) was
discovered in 1994 (Chang et al., 1994). The virus belongs to the
Rhadinovirus genus of gamma 2 herpesvirus family, and is closely
related to Epstein Barr Virus (EBV), Herpes virus Saimiri (HVS) and
Rhesus Rhadino virus (RRV) (Moore and Chang, 2001). KSHV has
been identiﬁed in all forms of Kaposis Sarcoma (KS) and is also
associated with the development of primary effusion lymphomasll rights reserved.
gy Department, Institute of
ovia del Mediodı´a, Km 6 1/2,
anuscript.(PEL) and multi-centric Castleman’s disease (MCD) (Ablashi et al.,
2002; Boshoff and Moore, 1997; Cesarman et al., 1995; Sunil, Reid,
and Lechowicz, 2010). Unlike other human herpes viruses, HHV-8 is
not ubiquitous, demonstrating an extremely unusual distribution
pattern around the world. Hence, many questions arise about the
origin of HHV-8 and its mode of transmission (Boshoff, 2002;
Boshoff and Weiss, 2001; Tornesello et al., 2010).
The KSHV genome encodes more than 80 open reading frames
(ORF), including 15 unique open reading frames and several
human gene homologs (associated with immune response and
cell cycle regulation) strongly suggesting that HHV-8 promotes
certain type of cell proliferation that could be associated with
tumorigenesis (Thomas et al., 2011; Ye, Lei, and Gao, 2011).
At the extreme left hand side (LHS) of the KSHV genome is
ORF-K1, in the position equivalent to the LMP1 of EBV, which
encodes an early lytic transmembrane glycoprotein of 46 kDa.
Sequence analysis has demonstrated that K1 gene is extremely
variably, with up to 85% and 60% divergence at the nucleotide (nt)
and amino acid (aa) levels, respectively within the two variable
regions (VR). The full length ORF K1 protein is predicted to encode
V. Kourı´ et al. / Virology 432 (2012) 361–369362a transmembrane protein (1–289 aa), consisting of three major
regions: (1) an extracellular domain (1–228 aa) with an amino
terminal signal peptide and an immunoglobulin receptor-like
domain with two variable regions VR1 (54–93 aa) and VR2
(191–228 aa), (2) a transmembrane domain (229–261 aa) and
(3) a C terminal cytoplasmic tail (262–289 aa) which contains an
immunoglobulin-receptor tyrosine-based activation motif (ITAM),
respectively (Zong et al., 1999; Lacoste et al., 2000).
Phylogenetic analysis using ORF K1 sequences from different
geographic regions and different forms of KS as well as BCBL DNA
samples, enable the deﬁnition of four major subtypes (A, B, C, and D)
and at least 13 distinct variants of KSHV (Zong et al., 2002). More
recently subtype E was described in populations of Amerindians
from Brazil and Ecuador (Biggar et al., 2000; Mohanna et al., 2005;
Whitby et al., 2004). KSHV subtypes, as deﬁned by K1 sequences
have speciﬁc geographic distribution patterns worldwide. Isolates
from Europe, Asia and the United States are generally A and C
subtypes and those from Africa are predominantly B and A5 subtype;
the rare D subtype appears exclusively from the Paciﬁc Islands
(Hayward and Zong, 2007; Tornesello et al., 2010).
In Cuba, a country from the Caribbean region, there are few
pre-existent reports of KS prior to the HIV era. Since the beginning
of the Cuban HIV epidemic in 1986 until the end of the year 2010,
233 patients had been diagnosed with AIDS-KS, which represents
around a 1.6% of the Cuban HIV population. In the last decade, the
incidence of KS remains undiminished despite the wide use of
antiretroviral (ARV) therapy after 2001 (an average of 1.9% from
2006–2010) (National Registry of HIV, Cuba, 2010).
Previous serological screening for KSHV LANA antibodies (Abs)
in Cuban population showed that, 85% of patients with AIDS-KS,
30.2% of HIV patients without KS, 1.2% of blood donors and 0% of
transplanted patients had Abs (Kouri et al., 2004). Furthermore,
previous reports regarding molecular epidemiology of KSHV in
Cuba have shown a wide range of KSHV subtypes among the
Cuban population (Kouri et al., 2005a; Kouri et al., 2005b; Kouri
et al., 2007b).
Molecular epidemiological studies of Kaposi’s sarcoma-asso-
ciated herpesvirus (KSHV) have concentrated on characterization
of viral strains in tumour biopsies from Kaposi’s sarcoma (KS)
patients, mostly obtained in the United States and Europe. Tumour
biopsies are a convenient source of viral DNA, as they have a high
viral load compared to peripheral blood. However, sequences
obtained from biopsies may not be representative of viral strains
in asymptomatic subjects and information on ethnicity is often not
available. Hence, in the current study, a population-based approach
has been used to investigate the molecular epidemiology of KSHV
from different populations in Cuba, including patients with KS, PEL,Table 1
Clinical, epidemiological and demographical features of the investigated Cuban sample
Type of patient Epidemic KS Contact of KS p
69 12
Type of sample KS lesion PBMC
73 12
Sex Male
83
Sexual orientation Homo-Bisexual
72
Age average: 35,9 o 30 30–50
21 57
Ethnic Origin White Black
59 10
Country of HIV/KSHV infection Cuba
85
Period of KS diagnosis 1991–2000 2001–2004
16 33
Abreviations: Kaposis Sarcoma (KS); peripheral blood mononuclear cells (PBMC).lymphadenopathy and asymptomatic individuals infected with
KSHV. The present study also aims to evaluate the variation in the
distribution of KSHV subtypes from all available KSHV Cuban
sequences from 1991–2009.Results
Patient’s demographics, clinical and histopathological proﬁle
In the current study, a total of 90 KSHV sequences were
analyzed (54 previously reported; 36 new samples). The main
clinical and epidemiological features are summarized in Table 1.
Epidemiological information provided by the patients revealed
that ﬁve patients lived in Africa and, of them, four became infected
with HIV thence. Among them include the ﬁrst two AIDS-KS cases
diagnosed in Cuba (Cu44/91 and Cu49/91). Three out of the ﬁve were
epidemic KS, 1 was a classic KS (HIV-seronegative) and 1 was an HIV-
1 seropositive woman asymptomatically infected with HHV-8 (whose
husband had epidemic KS). Presentation of KS was cutaneous (65.9%),
mucocutaneous (8.7%) and visceral (25.4%), respectively. Fourty-four
percentage of the lesions presented belonged to patch histological
stage of KS, while 36.2% and 19% were nodular and plaque stage,
respectively (Grayson and Pantanowitz, 2008). The most frequent
localization of the KS lesions were the upper limbs (UL), followed by
the lower limbs (LL) and the trunk (data not shown).
Overall distribution of KSHV subtypes in Cuban patients
The overall distribution of KSHV subtypes from patients
sampled between 1991–2009 demonstrates the prevalence of a
broad range of genotypes of HHV-8 among Cuban patients with
KS, asymptomatic contacts, patients with primary effusion lym-
phoma and lymph node lesions. The subtype A (A1–A4 variants) is
the most prevalent (36 samples, 40%), followed by subtype B (22
samples, 24.4%). Subtypes C, A5 and E were also detected but
prevalent at much lower frequencies. Despite the wide variety of
HHV-8 subtypes detected among Cuban patients, the subtype D
has not yet been reported. (Fig. 1, Table 2).
When analyzing the temporal variation in the prevalence of
HHV-8 subtypes in Cuban patients during 1991–2009 (consider-
ing that the investigated sequences correspond to the same
sample used for diagnosis of KS/KSHV), the present study reveals
the following trend:
Although most of the previously described KSHV subtypes
were present from the beginning of the Cuban HIV epidemic, over
the past ﬁve years, HHV-8 subtype A (predominantly prevalents. Kaposis Sarcoma (KS), peripheral blood mononuclear cells (PBMC).
atient Classic KS Other
3 6
Lymphonode tissue Pericardial and pleural ﬂuid
3 2
Female
7
Heterosexual
18
451
12
Mulatto
21
A´frica
5
2005–2009
41
V. Kourı´ et al. / Virology 432 (2012) 361–369 363until 2004), has been steadily declining at the expense of a
signiﬁcant increase in HHV-8 subtype B, (OR: 4,6 CI: 1,6–13,2,
p¼0.006) (Fig. 2).
As is shown in Table 3, the average time interval from HIV to
KS diagnosis was 5.05 years and did not change when the period
of 1991–2004 (4.8 years) was analyzed apart from the period
after 2005 (5.2 years). Hence, it is unlikely that patients infected
with HHV-8 subtype B, analyzed in the later period, were infected
with the virus or had pre-existent KS long before their HIV
diagnosis, compare with the patients analyzed in the ﬁrst period.
Further, the seroprevalence of HHV-8 in Cuba is very low in non-
HIV populations (1.2%) increasing in HIV populations (30.2%)
(Kouri et al., 2004).
Interestingly, heterosexual individual were more likely to be
infected with Subtype B of KSHV than with other subtypes (OR:
3.63, CI: 1.2–10.98, p¼0.03), and patients who became infected with
HIV/KSHV in Africa were signiﬁcantly associated to have Subtype B
than patients infected in Cuba (p¼0.0003) (Tables 2 and 3).
The inference of these patients being infected with HHV-8 in
Africa is based on the following epidemiological information:
Four of them were HT male, who declared to have engaged in
unprotected sex with native African women; the ﬁfth patient was
the wife (Cub91/07þ) of one of these individuals (Cub90/07), she
was asymptomatic for KSHV. Four out of the ﬁve were also
infected with HIV, and this diagnosis was performed shortly after
their return from Africa, with exception of patient cu49/91
(returned from Africa prior to HIV/AIDS epidemic becoming
evident worldwide). Finally, the remaining case of subtype B
had a history of traveling to Africa and match with an HIV-
seronegative patient who developed classic KS (cu-683/06) and is
reported to have lived in Mozambique (1978–1980), where he
had heterosexual sex with a native (Kouri et al., 2007b). Further-
more, these patients lived in Africa prior to the more recent
expansion of Subtype B (although only 2 [cu44/91 and cu49/91]
developed KS before this period).
In addition, we also found association of KSHV subtype B with
nodular histological stage of KS lesions (OR 4.2, CI: 1.1 to 15.7,
p¼0.04). On the other hand, both subtype B and others were
detected in different KS types (epidemic and classic), in asympto-
matic infections (contacts) in the PEL and tissues of lymph nodes.
Hence, clinical association between HHV-8 subtypes and type of
KSHV-related disease could not be established (Tables 2 and 3).
Conversely, an association of age over 40 years and patients
harbouring Subtype E was observed as opposed to the other subtypes
(OR: 22.19, CI: 1.2–415.4 p¼0.01). Likewise initial stages of KS
lesions were more likely to harbor subtype E (OR: 16,42, CI:1,5–
306, 5 p¼0.01). No association between HHV-8 subtypes and type of
KSHV-associated disease, type of sample or localization of KSHV
lesion was observed. Further, no other epidemiological, demographic
and clinical associations were observed (Tables 2, and 3).
KSHV K1 sequence variation among Cuban samples
The overall estimation of evolutionary divergence among all ORF
K1 nucleotide sequences was calculated as the number of amino acid
differences per site between the sequences, using the MEGA package
version 5. The analysis used 90 amino acid sequences included in the
current study. All positions containing gaps were eliminated. The
average divergence among all sequences was 0.2 (20%) (range 0–0.4),Fig. 1. Phylogenetic tree was constructed based on Maximum Likelihood
(ML) statistical method with the K1 aminoacid sequences (39–246 aa) and
1000 iterations (bootstrap) using Mega program, version 5. The different sub-
types of HHV-8 sequenced from the 54 samples of Cuban patients previously
reported are labeled with black triangles, while the novel 36 samples genera-
ted towards this study are labeled with black circles. Subtypes are shown in
brackets.
Table 2
Association of KSHV subtypes with epidemiological, demographical and clinical characteristics of the study cohort.
KSHV subtype A1–A4 A5 B C E
36 12 22 15 5
Sex M F M F M F M F M F
34 3 12 0 20 2 14 1 4 1
Sexual orientation MSM HT MSM HT MSM HT MSM HT MSM HT
31 5 10 2 14 8 14 1 3 2
Ethnic origin W B M W B M W B M W B M W B M
26 3 8 9 1 2 15 3 4 7 2 6 4 0 1
Average of age 35,5 35,2 36,2 33,4 48,2
Country of HIV/KSHV infection Cuba Africa Cuba Africa Cuba Africa Cuba Africa Cuba Africa
37 0 12 0 17 5 15 0 5 0
Type of patient E SC C O E SC C O E SC C O E SC C O E SC C O
29 5 1 1 10 1 0 1 17 2 1 2 10 4 0 1 4 0 1 0
Abreviations: Male (M); Female (F); Male who have sex with male (MSM); Heterosexual (HT); White (W); Black (B); Mulatto (M); Epidemic KS (E); Sexual contact (SC);
Classic KS (C); Other (O).
Fig. 2. Variation in the prevalence of KSHV subtypes in Cuban patients during 1991–2009.
V. Kourı´ et al. / Virology 432 (2012) 361–369364however, intra-subtype distances were on an average 0.1. The great-
est divergence was observed when comparing subtype B samples
with those of subtype A and C (0.4; 40%) (data not shown). Subtype A
(variants A1–A4) had several point mutations. In addition, there are
two pairs of samples of Subtype B of KSHV belonging to two couples
engaging in a stable sexual relationship (Samples: Cub-626/06–Cub-
593/06 and Cub-90/07–Cub-91/07) (Table 3); as expected, the two
related samples are almost identical (Figs. 1 and 3).Discussion
There has been a notable decline in the incidence of KS from
the pre-HAART era to the HAART era, supporting the hypothesis
that immune impairment is permissive of KS (Aldenhoven et al.,
2006). However, in Cuba, despite the wide use of ARV therapy
since 2001 (free of cost and available for all HIV infected
individuals), no decline in the incidence of KS is observed. Similar
to our ﬁnding, Maurer et al. have also reported an increase in HIV
associated KS in individuals with suppressed HIV viral loads and
apparent immune reconstitution (Maurer etal., 2010). Similar
observations have also been made in the past by Krown (2003),
thus suggesting the need to further explore additional factors
involved in development and progression of KS.
Evidences of the geographic association of KSHV genotypes have
been extensively reported by several research groups world-wide
(Zong et al., 1999; Whitby et al., 2004; Hayward and Zong, 2007;
Kasolo et al., 2007). Furthermore, studies of infected emigrants haveshown that they harbor KSHV virus subtypes characteristic of their
countries of origin, but not their adopted homes (Boshoff and Weiss,
2001; Fouchard et al., 2000; Zhang et al., 2000).
Despite the data supporting an extremely strong linkage of the
KSHV subtype to the geographic origin of the infected host,
reported predominantly, Cuba interestingly shows an atypical
pattern of KSHV subtype distribution (Kouri et al., 2005a, 2005b,
2007b). This observation is further validated among the new
sample subset analyzed in the present study. Prior to our report,
few authors had reported Subtype B and A5 outside Africa (Kasolo
et al., 2007; White et al., 2008; Zong et al., 2007). A recent report
from Peru showed high HHV-8 diversity among patients with KS
(Cassar et al., 2010).
The signiﬁcant increase of KSHV Subtype B variant (observed
since 2004) in the present study is a novel and interesting
observation as it represents the ﬁrst evidence of subtype B
expansion in a country where a wide variety of KSHV subtypes
are prevalent. Previously, we had published the presence of HHV-
8 subtype B in Cuba, with no association to ethnic origin of
individuals. In the present study, we found signiﬁcant association
between KSHV subtype B and epidemiological history of having
traveled to Africa, as well as heterosexual behavior.
The epidemiological evidence presented (together with the
observation that the patients lived in Africa prior to the more recent
expansion of Subtype B) reinforces the hypothesis described pre-
viously regarding the origin of HHV-8 subtype B in Cuba, where it
could have been relatively recently introduced from Cubans who
were working in Africa since the late 1970s.
Table 3
Epidemiological, demographical and clinical features of Cuban patients with KSHV Subtype B.
Sample
ID
HIV
status
Date of HIV
diagnosis
Date of
AIDS
Date of KS
diagnosis
Date of KSHV sample
sequenced
Period of living in
Africa (years)
Time since
HIV to KS
Sex Sexual
orientation
Ethnic
origin
Agen Sample Type of patient Histological stages of
KS lessions
Cu44/91 Positive 1989 1991 1991 1991 1986–1988 3 M HT W 26 Tissue Epidemic KS Nodular
Cu49/91 Positive 1986 1990 1991 1991 1976–1979 5 M HT M 32 Tissue Epidemic KS Nodular
Cu14/98 Positive 1991 1998 1998 1998 – 7 M MSM W 37 Tissue Epidemic KS Patch
C48/98 Positive 1992 1996 1998 1998 – 6 M MSM W 31 Tissue Epidemic KS Patch
C62/01 Positive 1998 1998 2001 2001 – 3 M MSM W 18 Tissue Epidemic KS Patch
Cu11/02 Positive 2002 2002 2002 2002 – 5 M MSM B 30 Tissue Epidemic KS Plaque
Cu24/05 Positive 1998 2002 2005 2005 – 7 M MSM W 26 Tissue Epidemic KS Nodular
Cub2032/
05
Positive 2001 2005 2005 2005 – 4 M MSM W 43 Tissue Epidemic KS Patch
Cub-626/
06#
Positive 2003 2006 2006 2006 – 3 M HT W 38 Tissue Epidemic KS Nodular
Cu-683/
06
Negative – – 2006 2006 1978–1980 M HT W 58 Tissue Classic KS Nodular
CU-B06/
636
Negative – – 2006 2006 – M MSM W 39 Tissue MSM KS Patch
Cub1109/
06
Positive 2005 2005 2006 2006 – 1 M MSM W 37 Tissue Epidemic KS Patch
Cub557/
06
Positive 2001 2001 2006 2006 – 5 M MSM W 39 Tissue Epidemic KS Nodular
Cub593/
06#
Positive 2005 – – 2006 – F HT W 36 PBMC SC –
Cub737/
06
Positive 2001 2006 2006 2006 – 5 M MSM W 45 Tissue Epidemic KS Plaque
Cub1835/
06
Positive 2001 2005 2006 2006 – 5 M MSM W 33 Tissue Epidemic KS Nodular
Cub553/
06
Positive 2002 2006 2006 2006 – 4 M MSM W 30 Tissue Epidemic KS Plaque
Cub427/
07
Positive 2001 2007 2007 2007 – 6 M HT M 31 PT PEL Na
Cub1373/
07
Positive 2003 2006 2007 2007 – 4 M MSM M 31 Tissue Epidemic KS Patch
Cub90/
07þ
Positive 1995 2003 2007 2007 1986–1994 12 M HT B 53 Tissue Epidemic KS Na
Cub91/
07þ
Positive 1995 2008 – 2007 1986–1994 F HT B 51 PBMC SC –
K1-
Cu17 -
T/09
Positive 2003 2009 2009 2009 - 6 M MSM M 34 LNT Epidemic KS. Only
ganglionar
Na
Age at KS diagnosis/or sampling for asymptomatic patients(n);
Sexual partners (þ); Sexual partners (#)
Abbreviations. Peripheral blood mononuclear cells (PBMC); Not available (na);Kaposis sarcoma (KS); heterosexual (HT); Males who have sex with men (MSM); Sexual contact (SC); Male (M); Female (F); White (W); Mulatto
(M); Black (M); Pleural tissue (PT); Lymphonode tissue (LNT).
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Fig. 3. Alignment of the amino acid sequences of the two variable regions, VR1 (54–93 aa) and VR2 (191–228 aa) of the HHV-8 K1 protein generated from nucleotide
sequences for each of the 90 samples investigated. Conserved regions (red dots), high consensus region (letters in red) and low consensus regions (letters in black), Cuban
sequences (dark blue diamond). The variable sites are based on the reference strain VG1-5 (Subtype B). (For interpretation of the references to color in this ﬁgure legend,
the reader is referred to the web version of this article.)
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subtype in Cuba can be accounted by the assumption that the
Subtype A was pre-existent in Cuba before the HIV epidemic
(probably introduced by the Spanish colonizers) and thus at the
onset of the HIV epidemic these subtypes were the ones to be
initially disseminated among AIDS patients (10–20 years ago)
(Fig. 2). Subsequently, the subtype B might have been more
recently introduced by heterosexual route and expanded due to
the homosexual practices.
The initial patients of HIV/AIDS in Cuba, were heterosexual
individuals infected in Africa. Nevertheless, shortly after the onset
of HIV epidemic, the pattern of the epidemic changed to MSM,
and currently, more than 70% of the Cuban HIV individuals are
MSM (National Registry of HIV/ AIDS, Cuba). Considering this, we
could think that the expansion of Subtype B may possibly berelated to a change in the sexual practices of the individuals
harboring Subtype B of KSHV.
The observed KSHV Subtype B expansion, although with less
probability, might be also collectively due to a better ﬁtness (an
adaptive evolution of this viral variant in comparison to the other
subtypes) resulting in better transmission and/or higher replication
capacity, together with viral survival mechanisms that favor immune
evasion by the virus.
Despite this interesting ﬁnding of the present study, we
recognize that the sequence of only the ORF-K1 segment (at the
extreme LHS of the HHV-8 genome) is not necessarily represen-
tative of the subtype structure of the bulk of the rest of the KSHV
genome. Hence it would also be critically important to perform a
further study of different regions of the genome to document
what kind of overall genomes these cases have.
V. Kourı´ et al. / Virology 432 (2012) 361–369 367We also observed an association of KSHV subtype B with
nodular histological stage of KS lesions (OR 4.2, CI: 1.1 to 15.7,
p¼0.04), which may be related to a more rapid evolution and/or
increased virulence of this viral variant. However, this observa-
tion warrants further study as there are no consistent reports
linking HHV-8 subtypes with epidemiological variants of KS,
clinical stage or with the evolution of the disease. Although a
previous report from Mancuso et al., associated HHV-8 subtype A
with rapidly evolving classic Kaposi’s Sarcoma, subtype B
remained unanalyzed in that sample set (Mancuso et al., 2008).
An alternate hypothesis for the Subtype B expansion in Cuba
might be the recombination events, between subtype B with
other viral KSHV variant (perhaps A5), resulting in a recombinant
virus with selective advantage and more aggressive evolution, as
has been previously proposed by Hayward and Zong, 2007.
However, since only the ORF K1 gene was analyzed in the present
samples, no evidence of recombination within this gene was
observed for subtype B in these KSHV samples. Further studies
including other viral regions (ORF26, K15, ORF73), should be
perform in order to conﬁrm recombination mechanism.
It is also interesting to note the identiﬁcation of ﬁve Cuban cases
with subtype E of the virus (all diagnosed post 2003). Conversely,
subtype E seems to be associated with slower progression of the
disease in the present study, since it was signiﬁcantly detected in
persons older than 40 years and with initial clinical stages of KS. This
observation is in concordance with earlier reports on KSHV subtype E
coming from blood isolates in asymtomatic amerindian populations
(Biggar et al., 2000; Mohanna et al., 2005; Whitby et al., 2004). In the
context of plausibility of such an origin of this viral variant, it is
important to consider that the Cuban Indians that came from the
American continent might have harbored this HHV-8 variant, how-
ever, since they were almost exterminated by the Spanish colonizers,
it is not feasible to perform such investigations at present. It is
surprising that the subtype E, has not been reported in either North
American Indians or remnants of Mayan/Aztec populations in Mexico.
Perhaps it may have remained unreported due to its rare prevalence
and the present reported cases may be representative vestiges of the
ancient Mayan-like Central Amerindian virus as well as the A/Cs of
Spanish/Portuguese origin or evenmodern chimeras between the two.
The mutation rates in ORF K1 is approximately similar to those
described for genes in other human pathogens (for instance, HIV-
1 env). The exact mechanisms of this high variability is not
known, as there is no available evidence for a herpesvirus error-
prone replication mechanism that would permit rapid positive
selection of the ORF K1 gene (Uldrick and Whitby, 2011; Zong
et al., 2002). However, isolates of K1 subtypes from different
lesions in a single individual as well as between sexual partners
infected with HHV-8, usually detected the same viral subtype
with almost identical sequences. This is exempliﬁed by the two
new pair of sequences obtained from two sexual partners (Kouri
et al., 2005b, 2007a; Zong et al., 2002).
In conclusion, the present data demonstrates, for the ﬁrst time,
an expansion of KSHV Subtype B in Cuba in the last years, suggesting
that it may be reﬂective of a change in human behavioural pattern
among the individuals harbouring Subtype B of KSHV.Material and methods
Patient samples
Ninety KSHV samples from Cuban individuals were analyzed in
the present study, including 73 tissues from biopsy or autopsy from
patients with conﬁrmed histological diagnosis of KS (4 HIV serone-
gatives and 69 with Epidemic KS), 3 lymph node tissue from
patients with lymphadenopathy (one diagnosed as vasoproliferativelesion of lymph node and 2 as KS inﬁltration of the lymph node,
without skin lesion), 2 samples from primary effusion lymphoma
(PEL) (pericardial ﬂuid and pleural tissue) and 12 PBMC from KSHV
infected individuals without clinical evidence of KS. These indivi-
duals were diagnosed between 1991 to 2009 and the samples were
archived in the pathology department of Institute of Tropical
Medicine Pedro Kourı´ (IPK) or obtained directly from live KS patients
or asymptomatic contacts /(Table 1).
All patients samples conﬁrmed histologically as KS, and asymp-
tomatic contacts had previously been tested for KSHV Infection,
using multiplex PCR (Pozo and Tenorio; 1999) or Real-Time PCR
(Watzinger et al., 2004). The samples used for the diagnosis of KS
and/ or KSHV (in asymptomatics) and the sequencing study were
the same. In case of patients with KS, PEL or lymphadenopathy, the
sequencing was performed from the affected tissue whereas for
asymptomatic KSHV-infected individuals, it was made from PBMC.
All information concerning clinical, epidemiological, demographic
and histopathological data from the patients with KSHV infection
was obtained through a questionnaire (in case of live patients), from
clinical records of the patients and/or from the Cubans National
Registry of HIV/AIDS. Some of these information had been already
published (for the 54 KSHV samples previously reported) (Kouri
et al., 2004, 2005a, 2005b, 2007a, 2007b) while others are shown
only in the present study (for the 36 new samples generated and
subtyped in the present study; see below).
Ethics
This research has been approved by the Ethical Committee of
IPK, and complies with the principles laid down in the Declaration
of Helsinki. All live subjects included in the study, gave informed
consent to participate in it.
DNA extraction
Tissue from parafﬁn block sections were ﬁrst treated with Xylene,
in order to eliminate the parafﬁn, then all genomic DNA (gDNA)
either from tissues or PBMC were extracted using the QIAmp DNA
Minikit (QIAGEN, Germany) following the manufacturer’s protocol.
Polymerase chain reaction
K1 genes were ampliﬁed by a two-step nested PCR technique.
5 ml (200 ng) of gDNA and 2 mL of PCR products were used for the
ﬁrst and the second round PCR ampliﬁcation, respectively. For the
ﬁrst PCR reaction, primers 2089/2088 (1063 bp) that covered the
complete 870 bp K1 coding region and for the nested PCR reaction
the internal primers 2090/2508 which amplify a fragment of
621 bp (117–738 nt), spanning the two VR, were used as pre-
viously described by Zong et al., 1999. Ampliﬁcations were carried
out on a thermal cycler (VWR, Germany) at 94 1C for 5 min,
followed by 94 1C for 1 min, 50 1C for annealing for 1 min and
extension at 72 1C for 1 min over 40 cycles. Negative (water and
uninfected cellular DNA) and positive (gDNA from BCBL cells,
KSHV-infected PEL cell line) controls were included in each assay.
An aliquot of nested ampliﬁcation products were electrophoresed
in 2% agarose gel, stained with 0.5 mg/mL ethidium bromide, and
visualized under UV trans-illumination.
Sequencing
PCR products were puriﬁed using a commercial kit (QIAquick
PCR puriﬁcation kit, QIAGEN, Germany). The puriﬁed fragments
were sequenced by Beckman Coulter automatic sequencer (CEQ
TM 8800 Genetic Analysis – System Beckman Coulter, USA)
following the manufacturer’s protocol (Beckman Coulter Inc,
V. Kourı´ et al. / Virology 432 (2012) 361–369368USA). Brieﬂy, 25 to 100 fmol of puriﬁed PCR product, 5 pmol of
each primer and 8 mL of DTCS Quick Start Master Mix were mixed
to complete total volume of 20 mL. Fifty cycles of sequencing
reaction were carried out on a thermal cycler (VWR, Germany) at
96 1C for 2 min, followed by ﬁfty cycles at 96 1C for 30 s, 50 1C for
20 s and 60 1C for 4 min. All sequences were carried out with both
complementary strands, and overlapping primers (the same used
for nested PCR).Sequence and phylogenetic analysis
All sequences were assembled and edited using the Sequench-
erTM program, version 4.9 (Genes Codes Corporation, USA). DNA
sequences were aligned using the CLUSTAL X version 1.81.
Phylogenetic and molecular evolutionary analyses were con-
ducted using MEGA program, version 5 (Tamura et al., 2011).
Maximum likelihood analysis of aligned sequences were carried
out using the MEGA program, version 5. Phylogenetic trees of K1
aminoacid sequences (aa. 39–246) was constructed using the
Maximum Likelihood (ML) statistical method. The substitution
model was the Jones–Taylor–Thornton (JTT) and the ML heuristic
method was the Nearest-Neighbor-Interchange (NNI). Conﬁdence
levels for the branching pattern were estimated by bootstrapping.
Bootstrap values were obtained from a consensus tree based on
1000 randomly generated data sets. Thirty other aa sequences
available in GenBank were employed for phylogenetic analysis.
Distance estimation among all the aa samples were also per-
formed with MEGA program, version 5, using the bootstrap
method for variance estimation.
Accession numbers of Cuban K1 KSHV sequences analyzed in
this paper;
54 KSHV samples previously reported: AY850965 (C2/04),
AY850951 (C3/04), AY850952 (C4/04), AY850953 (C6/04),
AY850967 (C12/04), AY850951 (C13/04), AY850968 (C15/04),
AY850969 (C16/04), AY850970 (C19/04), AY850954 (C23/04),
AY623789 (cu44/91), AY623782 (cu49/91), AY623790 (cu50/95),
AY850971 (C38/97), AY850972 (C40/97), AY623769 (cu6/98),
AY623785 (cu14/98), AY850973 (C45/98), AY850981 (C48/98),
AY850974 (C50/99), AY850955 (C51/99), AY623768 (cu2/00),
AY623774 (cu23/02), AY623780 (cu37/00), AY850975 (C56/00),
AY850976 (C57/00), AY850956 (C61/00), AY850982 (C62/01),
AY623784 (cu10/01), AY623787 (cu19/03), AY623773 (cu21/01),
AY623770 (cu11/02), AY623771 (cu16/02), AY623777 (cu29/02),
AY623778 (cu33/02), AY623779 (cu35/02), AY623786 (cu17/02),
AY623772 (cu20/03), AY623775 (cu24/05), AY623776 (cu28/03),
AY623781 (cu39/03), AY623788 (cu42/03), AY623783 (cu51/03),
AY850983 (C64/03), AY850957 (C66/03), AY850977 (C67/04),
AY850978 (C68/04), AY850958 (C70/04), AY850979 (C71/04),
AY850980 (C75/04), EF153264 (Cu729/06), EF153263 (Cu44/06),
EF153266 (Cu683/06), EF153265 (CuB06/636).
36 new KSHV samples generated in this paper: FJ986131
(Cub626/06), FJ986117(Cub2033/05), FJ986123 (Cub2032/05),
FJ986136 (Cub1105/06), FJ986115 (Cub209/06), FJ986122
(Cub1064/06), FJ986140 (Cub134/06), FJ986141 (Cub234/06),
FJ986142 (Cub1106/06), FJ986143 (Cub556I/06), FJ986113
(CubB06-576), FJ986118 (Cub758/06), FJ986132 (Cub1109/06),
FJ986128 (Cub557/06), FJ986130 (Cub59306), FJ986126
(Cub737/06), FJ986133 (Cub1835/06), FJ986124 (Cub553/06),
FJ986135 (Cub9/07), FJ986137 (Cub127/07), FJ986121 (Cub473/
07), FJ986119 (Cub310/07), FJ986138 (Cub286/07), FJ986144
(Cub375/07), FJ986114 (Cub81/07), FJ986134 (Cub427/07),
FJ986129 (Cub1373/07), FJ986125 (Cub90/07), FJ986127
(Cub91/07), FJ986139 (Cub296/09), FJ986116 (Cub551/06),
FJ986120 (CubB06/603), GU475457 (1T/2009), GU475458 (17T/
2009), GU475459 (32TLN/2009), GU475460 (50T/2009).Acknowledgments
This work was partially supported by Joachim Kuhlmann HIV-
AIDS Foundation and by the Cuban Ministry of Health.References
Ablashi, D.V., Chatlynne, L.G., Whitman Jr., J.E., Cesarman, E., 2002. Spectrum of
Kaposi’s Sarcoma-associated herpesvirus, or Human Herpesvirus 8, diseases.
Clin. Microbiol. Rev. 15 (3), 439–464.
Aldenhoven, M., Barlo, N.P., Sanders, C.J., 2006. Therapeutic strategies for epidemic
Kaposi’s Sarcoma. Int. J. STD. AIDS 17 (9), 571–578.
Biggar, R.J., Whitby, D., Marshall, V., Linhares, A.C., Black, F., 2000. Human
Herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a
new subtype. J. Infect. Dis 181 (5), 1562–1568.
Boshoff, C., 2002. Kaposi’s Sarcoma biology. IUBMB Life 53 (4-5), 259–261.
Boshoff, C., Moore, P.S., 1997. Kaposi’s Sarcoma-associated herpesvirus: a newly
recognized pathogen. AIDS. Clin. Rev., 323–347.
Boshoff, C., Weiss, R.A., 2001. Epidemiology and pathogenesis of Kaposi’s Sarcoma-
associated herpesvirus. Philos. Trans R. Soc. Lond B. Biol. Sci. 356 (1408),
517–534.
Cassar, O., Blondot, M.L., Mohanna, S., Jouvion, G., Bravo, F., Maco, V., Duprez, R.,
Huerre, M., Gotuzzo, E., Gessain, A., 2010. Human herpesvirus 8 genotype E in
patients with Kaposi Sarcoma, Peru. Emerg. Infect. Dis. 16 (9), 1459–1462.
Cesarman, E., Chang, Y., Moore, P.S., Said, J.W., Knowles, D.M., 1995. Kaposi’s
Sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-
cavity-based lymphomas. N. Engl. J. Med. 332 (18), 1186–1191.
Chang, Y., Cesarman, E., Pessin, M.S., Lee, F., Culpepper, J., Knowles, D.M., Moore,
P.S., 1994. Identiﬁcation of herpesvirus-like DNA sequences in AIDS-associated
Kaposi’s Sarcoma. Science 266 (5192), 1865–1869.
Fouchard, N., Lacoste, V., Couppie, P., Develoux, M., Mauclere, P., Michel, P., Herve,
V., Pradinaud, R., Bestetti, G., Huerre, M., Tekaia, F., de, G., Gessain, A., 2000.
Detection and genetic polymorphism of human herpes virus type 8 in endemic
or epidemic Kaposi’s Sarcoma from West and Central Africa, and South
America. Int. J. Cancer 85 (2), 166–170.
Goetschel, G., 1959. Late appearance of Kaposi’s disease in a 78-year-old person.
Bull. Soc. Fr. Dermatol. Syphiligr. 66, 154–156.
Grayson, W., Pantanowitz, L., 2008. Histological variants of cutaneous Kaposi
Sarcoma. Diagn. Pathol. 3, 31.
Hayward, G.S., Zong, J.C., 2007. Modern evolutionary history of the human KSHV
genome. Curr. Top Microbiol. Immunol. 312, 1–42.
Iversen, O.H., Wetteland, P., Jervell, J.A., Westlie, L.O., 1980. Kaposi’s Sarcoma in a
renal allograft recipient under longterm immunosuppressive therapy. Scand. J.
Urol. Nephrol. 14 (1), 125–128.
Kasolo, F.C., Spinks, J., Bima, H., Bates, M., Gompels, U.A., 2007. Diverse genotypes
of Kaposi’s Sarcoma associated herpesvirus (KSHV) identiﬁed in infant blood
infections in African childhood-KS and HIV/AIDS endemic region. J. Med. Virol.
79 (10), 1555–1561.
Kouri, V., Eng, S.M., Rodriguez, M.E., Resik, S., Orraca, O., Moore, P.S., Chang, Y.,
2004. Seroprevalence of Kaposi’s Sarcoma-associated herpesvirus in various
populations in Cuba. Rev. Panam. Salud Publica 15 (5), 320–325.
Kouri, V., Liang, X., Rodriguez, M.E., Capo, V., Resik, S., Barrios, J., Mantecon, B.,
Blanco, O., Means, R., Jung, J.U., Lee, B.S., Hengge, U.R., 2005a. Molecular
epidemiology and KSHV K1 subtypes in a Cuban AIDS–Kaposi’s Sarcoma
population. AIDS 19 (9), 984–987.
Kouri, V., Marini, A., Doroudi, R., Nambiar, S., Rodriguez, M.E., Capo, V., Resik, S.,
Blanco, O., Martinez, A., Hengge, U.R., 2005b. Molecular epidemiology of
Kaposi’s Sarcoma herpesvirus (KSHV) in Cuban and German patients with
Kaposi’s Sarcoma (KS) and asymptomatic sexual contacts. Virology 337 (2),
297–303.
Kouri, V., Marini, A., Nambiar, S., Rodriguez, M.E., Capo, V., Resik, S., Mantecon, B.,
Martinez, A., Kohler-Hansner, K.J., Hengge, U.R., 2007a. Nearly identical strains
of human herpesvirus 8 in couples discordant for Kaposi’s Sarcoma. AIDS 21
(6), 765–768.
Kouri, V., Martinez, P.A., Acosta, B., Rodriguez, M.E., Blanco, O., Capo, V., Gonzalez,
R.L., Viera, J., Hengge, U.R., 2007b. First report of Kaposi’s Sarcoma-associated
herpesvirus DNA sequences from Cuban Kaposi’s Sarcoma patients without
HIV infection. AIDS 21 (15), 2113–2115.
Krown, S.E., 2003. Therapy of AIDS-associated Kaposi’s Sarcoma: targeting patho-
genetic mechanisms. Hematol. Oncol. Clin. North Am. 17 (3), 763–783.
Lacoste, V., Judde, J.G., Briere, J., Tulliez, M., Garin, B., Kassa-Kelembho, E., Morvan,
J., Couppie, P., Clyti, E., Forteza Vila, J., Rio, B., Delmer, A., Mauclere, P., Gessain,
A., 2000. Molecular epidemiology of human herpesvirus 8 in africa: both B and
A5 K1 genotypes, as well as the M and P genotypes of K14.1/K15 loci, are
frequent and widespread. Virol. 278 (1), 60–74.
Mancuso, R., Bifﬁ, R., Valli, M., Bellinvia, M., Tourlaki, A., Ferrucci, S., Brambilla, L.,
Delbue, S., Ferrante, P., Tinelli, C., Clerici, M., 2008. HHV8 a subtype is
associated with rapidly evolving classic Kaposi’s Sarcoma. J. Med. Virol. 80
(12), 2153–2160.
Maurer, T., Leslie, K., Unemori, P., 2010. Response to: a retrospective analysis of
AIDS-associated Kaposi’s sarcoma in patients with undetectable HIV viral
loads and CD4 counts greater than 300 cells/mm(3). J. Int. Assoc. Physicians
AIDS Care (Chic.) 9 (2), 73.
V. Kourı´ et al. / Virology 432 (2012) 361–369 369Mohanna, S., Maco, V., Bravo, F., Gotuzzo, E., 2005. Epidemiology and clinical
characteristics of classic Kaposi’s Sarcoma, seroprevalence, and variants of
human herpesvirus 8 in South America: a critical review of an old disease. Int.
J. Infect. Dis. 9 (5), 239–250.
Moore, P.S., Chang, Y., 2001. Molecular virology of Kaposi’s Sarcoma-associated
herpesvirus. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 356 (1408), 499–516.
Pozo, F., Tenorio, A., 1999. Detection and typing of lymphotropic herpesviruses by
multiplex polymerase chain reaction. J. Virol. Methods. 79 (1), 9–19.
Schwartz, R.A., 2004. Kaposi’s Sarcoma: an update. J. Surg. Oncol. 87 (3), 146–151.
Sengupta, S.K., Edwards, K., Blair, A., Hamilton, D.R., Niblet, J.S., 1986. Childhood
Kaposi’s Sarcoma in Papua New Guinea. Aust. Paediatr. J. 22 (4), 301–304.
Sunil, M., Reid, E., Lechowicz, M.J., 2010. Update on HHV-8-Associated Malignan-
cies. Curr. Infect. Dis. Rep. 12 (2), 147–154.
Thomas, S., Sindhu, C.B., Sreekumar, S., Sasidharan, P.K., 2011. AIDS associated
Kaposi’s Sarcoma. J. Assoc. Physicians India 59, 387–389.
Tornesello, M.L., Biryahwaho, B., Downing, R., Hatzakis, A., Alessi, E., Cusini, M.,
Ruocco, V., Katongole-Mbidde, E., Loquercio, G., Buonaguro, L., Buonaguro,
F.M., 2010. Human herpesvirus type 8 variants circulating in Europe, Africa
and North America in classic, endemic and epidemic Kaposi’s Sarcoma lesions
during pre-AIDS and AIDS era. Virology 398 (2), 280–289.
Uldrick, T.S., Whitby, D., 2011. Update on KSHV epidemiology, Kaposi Sarcoma
pathogenesis, and treatment of Kaposi Sarcoma. Cancer Lett. 305 (2), 150–162.
Watzinger, F., Suda, M., Preuner, S., Baumgartinger, R., Ebner, K., Baskova, L.,
Niesters, H.G., Lawitschka, A., Lion, T., 2004. Real-time quantitative PCR assays
for detection and monitoring of pathogenic human viruses in immunosup-
pressed pediatric patients. J. Clin. Microbiol. 42 (11), 5189–5198.Whitby, D., Marshall, V.A., Bagni, R.K., Wang, C.D., Gamache, C.J., Guzman, J.R.,
Kron, M., Ebbesen, P., Biggar, R.J., 2004. Genotypic characterization of Kaposi’s
Sarcoma-associated herpesvirus in asymptomatic infected subjects from
isolated populations. J. Gen. Virol. 85 (Pt 1), 155–163.
White, T., Hagen, M., Gudza, I., White, I.E., Ndemera, B., Gwanzura, L., Borok, M.,
Campbell, T.B., 2008. Genetic diversity of the Kaposi’s Sarcoma herpesvirus K1
protein in AIDS-KS in Zimbabwe. J. Clin. Virol. 42 (2), 165–171.
Ye, F., Lei, X., Gao, S.J., 2011. Mechanisms of Kaposi’s Sarcoma-associated
herpesvirus latency and reactivation. Adv. Virol., 2011.
Zhang, Y., Davis, T., Wang, X., Deng, J., Baillargeon, J., Yeh, T., Jenson, H., Gao, S., 2000.
Distinct distribution of rare US KSHV genotypes in south Texas. Implications for
KSHV epidemiology and evolution. Ann. Epidemiol. 10 (7), 470.
Zong, J., Ciufo, D.M., Viscidi, R., Alagiozoglou, L., Tyring, S., Rady, P., Orenstein, J.,
Boto, W., Kalumbuja, H., Romano, N., Melbye, M., Kang, G.H., Boshoff, C.,
Hayward, G.S., 2002. Genotypic analysis at multiple loci across Kaposi’s
Sarcoma herpesvirus (KSHV) DNA molecules: clustering patterns, novel
variants and chimerism. J. Clin. Virol. 23 (3), 119–148.
Zong, J.C., Ciufo, D.M., Alcendor, D.J., Wan, X., Nicholas, J., Browning, P.J., Rady, P.L.,
Tyring, S.K., Orenstein, J.M., Rabkin, C.S., Su, I.J., Powell, K.F., Croxson, M.,
Foreman, K.E., Nickoloff, B.J., Alkan, S., Hayward, G.S., 1999. High-level
variability in the ORF-K1 membrane protein gene at the left end of the
Kaposi’s Sarcoma-associated herpesvirus genome deﬁnes four major virus
subtypes and multiple variants or clades in different human populations. J.
Virol. 73 (5), 4156–4170.
Zong, J.C., Kajumbula, H., Boto, W., Hayward, G.S., 2007. Evaluation of global
clustering patterns and strain variation over an extended ORF26 gene locus
from Kaposi’s Sarcoma herpesvirus. J. Clin. Virol. 40 (1), 19–25.
